title: Pregnancy and rare bleeding disorders.
abstract: Rare bleeding disorders include deficiency of fibrinogen, prothrombin, factor V, factor VII, factor X, factor XI and factor XIII together with combined deficiency disorders, factor V+VIII deficiency, and deficiency of the vitamin K-dependent factors (factor II, VII, IX and X). They account for 3-5% of all inherited coagulation disorders. Due to their rarity, information about pregnancy complications and management is limited and mostly derived from case reports. Deficiency of fibrinogen and FXIII are both found to be strongly associated with increased risk of recurrent miscarriage and placental abruption. Factor replacement is used to reduce these risks. However, the risk of miscarriage and ante-partum complications is less clear in women with other bleeding disorders. Haemostatic abnormalities in women with rare bleeding disorders seem to persist throughout pregnancy especially if the defect is severe. Therefore women affected with these disorders are at risk of post-partum haemorrhage. The fetus can also be affected and potentially at risk of bleeding complications. Specialised multidisciplinary management is essential to minimise the potential maternal and neonatal complications and ensure an optimal outcome. This paper presents literature review for pregnancy complications in each of the rare bleeding disorders. In addition general principles for management of pregnancy, labour and delivery are discussed.
authors.affiliation: Haemophilia Centre and Thrombosis Unit, The Royal Free Hospital, London, UK. rezan.abdul-kadir@royalfree.nhs.uk
authors.forename: R
authors.initials: R
authors.lastname: Kadir
authors.forename: C
authors.initials: C
authors.lastname: Chi
authors.forename: P
authors.initials: P
authors.lastname: Bolton-Maggs
mesh_terms: D025861:Blood Coagulation Disorders, Inherited / Q000150:complications / Q000628:therapy*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D036861:Delivery, Obstetric / Q000379:methods*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*; D011256:Pregnancy Outcome; D011295:Prenatal Care / Q000379:methods*; D018570:Risk Assessment; D014592:Uterine Hemorrhage / Q000517:prevention & control*
chemical_list: D001779:Blood Coagulation Factors